FDA advisory panel

Expert committee recommends Avastin (bevacizumab) FDA approval for breast cancer be revoked

people with backs turned  An expert panel voted unanimously to remove the FDA approval for Bavacizumab (Avastin) in treatment of breast cancer.

Where's the beef? FDA rejects Contrave combination of two FDA approved medicines

two women angry IN a suprise move, the FDA decided against the advice of its own expert panel and apparently has postponed approval of the new weight loss drug called Contrave. The shocking aspect of this action is that Contrave is a combination of two medicines WHICH ARE ALREADY APPROVED BY THE FDA.

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.